Skip to main content
. 2014 Nov 19;9(11):e113057. doi: 10.1371/journal.pone.0113057

Table 3. Comparison on clinical characteristics of bronchiectasis patients with and without capsaicin cough hypersensitivity.

Parameter Cough hypersensitivity (n = 52) Normal cough sensitivity (n = 83) P value
Demographics Age (yrs) 45.4±15.3 44.2±12.7 0.62
Height (cm) 160.0±7.2 162.2±7.6 0.09
Weight (kg) 49.0 (8.2) 54.0 (11.5) <0.01
BMI (kg/m2) 19.4±2.6 21.1±3.2 <0.01
Females (No., %) 41 (78.8%) 42 (50.6%) <0.01
Disease-related characteristics Duration of bronchiectasis (yrs) 10.0 (15.0) 10.0 (17.0) 0.70
No. of bronchiectatic lobes 4.0 (3.0) 3.0 (3.0) <0.01
HRCT total score 8.0 (6.0) 5.0 (6.0) <0.01
24-hour sputum volume (ml) 20.0 (45.0) 15.0 (20.0) 0.07
BSI 7.4±3.5 5.0 (6.0) <0.01
Sputum purulence score 6.0 (1.0) 6.0 (2.0) 0.02
Spirometry FVC pred% 71.9±19.8 83.3±18.6 <0.01
FEV1 pred% 62.7±22.0 75.9±22.7 <0.01
FEV1/FVC (%) 71.4±13.2 76.8 (15.2) 0.12
MMEF pred% 48.6±27.8 63.0±31.0 <0.01
Cough-related parameters Cough symptom score 4.0 (2.0) 3.0 (2.0) <0.01
LCQ total score 11.7±3.9 13.2±3.7 0.03
Bronchiectasis etiology Post-infectious (No., %) 14 (26.9%) 23 (27.7%) 0.58
Immunodeficiency (No., %) 7 (13.5%) 6 (7.2%) 0.23
Gastroesophageal reflux (No., %) 2 (3.8%) 4 (4.8%) 0.87
Other known etiologies (No., %) 7 (13.5%) 15 (18.1%) 0.48
Idiopathic (No., %) 24 (46.2%) 27 (32.5%) 0.11
Sputum bacteriology Pseudomonas aeruginosa (No., %) 27 (51.9%) 16 (19.3%) <0.01
Other PPMs (No., %) 9 (17.3%) 29 (34.9%) 0.03
Commensals (No., %) 16 (30.8%) 38 (45.8%) 0.08

Numerical data were presented as mean ± standard deviation for normal distribution or otherwise median (interquartile range). Categorical data were expressed as number (percentage) and compared with chi-square test.

PPM: potentially pathogenic microorganism.

A minority of patients had dual etiologies, therefore the sum of proportion of individual etiologies was greater than 100%.

Data in boldface indicated statistical significance.